Zur Rose, a Swiss drugs wholesaler, announced that it has acquired the mail-order and diabetes activities of Germany-based Apotal Group.
Apotal, based in Bad Rothenfelde (Germany) was founded in 1980 by Heinz-Peter Fichter. Through the acquisition 1.1 million active customers will be transferred to Zur Rose subject to giving their consent. Expanding the client base to more than 8 million active customers will solidifiy the market leadership of Zur Rose Group in Europe.
A CMS team headed by lead partner Christoph Lächler (CMS Germany – pictured) advised the founder of the Apotal Group, Heinz-Peter Fichter, and other shareholders on all legal aspects of the sales process. The team further included partner Daniel Jenny (CMS Switzerland).
Ebner Stolz Gruppe acted as legal advisor to Zur Rose. The team was lead by Klaus Krink.